BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice
about
The role of T and B cells in human atherosclerosis and atherothrombosisB cells and atherosclerosis.B cells and humoral immunity in atherosclerosisBAFF knockout improves systemic inflammation via regulating adipose tissue distribution in high-fat diet-induced obesity.BAFF blockade prevents anti-drug antibody formation in a mouse model of Pompe diseaseVoluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects.A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting.Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum".Immune effector mechanisms implicated in atherosclerosis: from mice to humans.Role of toll-like receptor 4 on lupus lung injury and atherosclerosis in LPS-challenge ApoE⁻/⁻ mice.TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.Toll-Like Receptor (TLR)4 and MyD88 are Essential for Atheroprotection by Peritoneal B1a B Cells.Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis.Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE-/- mice by reducing lesion necrosis and inflammation.NKT Cell Hyporesponsiveness Leads to Unrestrained Accumulation of Marginal Zone B Cells in Hypercholesterolemic Apolipoprotein E-Deficient Mice.Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats.Opposing roles of B lymphocyte subsets in atherosclerosis.B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation.
P2860
Q27000791-18AC7E9C-1E8A-46A3-81F5-33958E5006DBQ30252928-714239D9-EEDC-4581-ADAF-2BCBD91BB04AQ33789638-47EFD48F-5D86-45B0-B877-4B93C2626E24Q35040658-5A597C7D-45E8-4AB5-A9FF-B76CA078FBD1Q35732635-226CE832-8917-47E9-9996-2A16399CB31CQ35850569-D8D9829E-E90E-482C-8AA5-397CDE2D2E11Q36261019-A780D322-0207-496B-A36F-0C7A19E66F35Q36654171-4AA6B053-6BB7-48AD-B6B0-75F3C9346367Q37150605-0594E6D5-EC52-4B82-89E2-2AFEF849BEE0Q37200114-0448AF11-B9A6-4138-A085-6AC8A679B1D3Q37494039-8FFAFCC5-8CA3-4C90-9545-7E60990D0DF2Q37556177-644864C6-66AA-4A45-B4BD-3E423DB21340Q38406177-5E7A24EC-DBA8-4F36-AD0B-7EEB878FF858Q38774904-3695DFC0-1D0B-4E9D-89F4-1CB6A9407043Q40896316-7CDA1B8A-0E61-4389-9AD5-7E09F0FFB46AQ48261376-3B47AC22-688B-48DA-9B90-ECEEADF0D33FQ50052184-E1895736-3CCA-423B-83E6-78E275532245Q50469720-A840D228-268F-49F3-BA5D-4E3DD8D75CB6Q51150401-20E57FE7-6E10-4153-B0EE-964FBFA7FC7AQ51594134-033F70BB-1333-4DD9-B747-980D8FC0F60A
P2860
BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
BAFF receptor mAb treatment am ...... lerosis in hyperlipidemic ApoE
@nl
BAFF receptor mAb treatment am ...... hyperlipidemic ApoE(-/-) mice
@ast
BAFF receptor mAb treatment am ...... hyperlipidemic ApoE(-/-) mice
@en
type
label
BAFF receptor mAb treatment am ...... lerosis in hyperlipidemic ApoE
@nl
BAFF receptor mAb treatment am ...... hyperlipidemic ApoE(-/-) mice
@ast
BAFF receptor mAb treatment am ...... hyperlipidemic ApoE(-/-) mice
@en
prefLabel
BAFF receptor mAb treatment am ...... lerosis in hyperlipidemic ApoE
@nl
BAFF receptor mAb treatment am ...... hyperlipidemic ApoE(-/-) mice
@ast
BAFF receptor mAb treatment am ...... hyperlipidemic ApoE(-/-) mice
@en
P2093
P2860
P1433
P1476
BAFF receptor mAb treatment am ...... hyperlipidemic ApoE(-/-) mice
@en
P2093
Alex Bobik
Antonius G Rolink
Ban-Hock Toh
Christopher Tay
Hamid Hosseini
Peter Kanellakis
Peter Tipping
P2860
P304
P356
10.1371/JOURNAL.PONE.0060430
P407
P577
2013-04-03T00:00:00Z